Norway's Nordic Halibut Q4 revenue rises 43% on increased biological asset production

Nordic Halibut AS

05/03/2026 07:10

Overview

Norway aquaculture firm's Q4 revenue rose 43% YoY

Q4 EBITDA reached NOK 48.5 mln

Company's biological asset production increased 18% in Q4

Outlook

Nordic Halibut did not provide specific guidance for future quarters or fiscal year

Result Drivers

INCREASED PRODUCTION - Biological asset production at sea increased by 18% in Q4, contributing to higher revenue

HIGHER HARVEST VOLUME - Harvested volume rose by 17% YoY, supporting revenue growth

STABLE SALES PRICE - Average sales price remained consistent with Q4 2024, indicating volume-driven revenue growth

Company press release: ID:nObiRL4yDa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 EBITDA
NOK 48.50 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the fishing & farming peer group is "buy"

Wall Street's median 12-month price target for Nordic Halibut AS is NOK30.00, about 41.5% above its March 4 closing price of NOK21.20

The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 28 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)